Results 241 to 250 of about 204,414 (356)

Androgen receptor expression in human ovarian and uterine tissue of long term androgen-treated transsexual women [PDF]

open access: green, 1994
S. Chadha   +4 more
openalex   +1 more source

Hormone Therapy Usage Is Associated With Adverse Cardiovascular Events in Prostate Cancer Patients of the All of Us Research Program Cohort

open access: yesThe Prostate, EarlyView.
ABSTRACT Background Hormone therapy (HT) has greatly improved overall survival for prostate cancer patients, but may also influence cardiovascular health in an already high‐risk population. Methods This retrospective cohort study examined participants in the All of Us Research Program with prostate cancer, had no prior history of adverse cardiovascular
Yuanchu J. Yang   +7 more
wiley   +1 more source

Transcriptional regulation of androgen receptor gene expression in Sertoli cells and other cell types [PDF]

open access: green, 1992
Leen J. Blok   +6 more
openalex   +1 more source

Real‐World Overall Survival Comparison of Enzalutamide and Abiraterone In First‐ and Second‐Line Setting of Metastatic Castration‐Resistant Prostate Cancer

open access: yesThe Prostate, EarlyView.
ABSTRACT Background While their indications overlap, no clinical trials have compared abiraterone and enzalutamide for overall survival (OS) in mCRPC. Methods A large, country‐wide health insurance database (2013‐2023) was assessed for the OS comparison between abiraterone and enzalutamide. Results Overall, 3497 patients were identified with first‐ (n =
András Horváth   +10 more
wiley   +1 more source

Small-molecule disruption of androgen receptor-dependent chromatin clusters. [PDF]

open access: yesProc Natl Acad Sci U S A
Kohrt SE   +29 more
europepmc   +1 more source

WB2838 (3-chloro-4-(2-amino-3-chlorophenyl)-pyrrole): Non-steroidal androgen-receptor antagonist produced by a Pseudomonas.

open access: bronze, 1993
Yasuhiro Hori   +7 more
openalex   +2 more sources

Genomic Signatures Correlating With Adverse Pathologic Features in Men Eligible for Active Surveillance

open access: yesThe Prostate, EarlyView.
ABSTRACT Background Genomic biomarkers offer opportunities to improve risk stratification for patients with prostate cancer. We performed a transcriptomic profile of active surveillance (AS)‐eligible patients who underwent radical prostatectomy (RP) to understand genomic associations with adverse pathologic features (APF) at RP.
Jamie Michael   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy